The Evolution of Ayushman Bharat Cancer Care

India’s flagship health insurance programme has significantly improved access to oncology treatments. Ayushman Bharat cancer care serves as a critical lifeline for rural and low-income populations facing high medical costs. However, while the scheme has covered millions of treatments, significant financial gaps persist. Experts emphasize that the current allocation often falls short of the comprehensive care required for long-term survival.

Bridging the Funding Gap

The FinCan study highlights that the program requires an annual budget of ₹33,000 crore to provide full standard-of-care services. Currently, the allocation stands at roughly ₹7,700 crore per year. Consequently, this disparity limits the ability of many families to access advanced therapies. Therefore, researchers recommend shifting from a ₹5 lakh annual cap to a ₹25 lakh revolving ceiling over five years. This change would allow patients to utilize more funds during high-cost treatment phases.

Prioritizing Early Diagnosis and Screening

Early detection remains the most effective way to reduce the economic and clinical burden of oncology. Furthermore, integrating diagnostic coverage into the scheme could save approximately ₹1,500 crore annually. By aligning screening protocols with global benchmarks, India could potentially save over 30,000 additional lives each year. Moreover, the 2025-26 Union Budget has already earmarked funds for 200 new day-care cancer centers to expand rural access. These steps indicate a positive move toward universal health coverage.

Frequently Asked Questions

Q1: How does the FinCan study suggest improving cancer funding?

The study recommends a ₹25 lakh revolving ceiling for families and a ₹10 lakh top-up for high-stage cancer patients.

Q2: Why is early diagnosis emphasized in the new study?

Early diagnosis and treatment initiation can save ₹1,500 crore annually and prevent late-stage suffering while improving survival rates.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Need expanded cancer coverage, early diagnosis under Ayushman Bharat: Study - ETHealthworld


2. National Health Authority. PM-JAY Cancer Care Data.


3. The Lancet Oncology. Enrolment and Cancer Care Outcomes in India.